Chapman & Hall/CRC Biostatistics Series- Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials
- Engels
- Paperback
- 9781032093505
- 30 juni 2021
- 376 pagina's
Samenvatting
Clinical trials require strategic thinking and innovative methods since some traditional methods are not adequate for the 21st century.To solve these problems requires good methodological skills, but also an in-depth knowledge of the practical problems we are dealing with and a strategic vision of the pig picture.
"This is truly an outstanding book. [It] brings together all of the latest research in clinical trials methodology and how it can be applied to drug development…. Chang et al provide applications to industry-supported trials. This will allow statisticians in the industry community to take these methods seriously." Jay Herson, Johns Hopkins University
The pharmaceutical industry's approach to drug discovery and development has rapidly transformed in the last decade from the more traditional Research and Development (R & D) approach to a more innovative approach in which strategies are employed to compress and optimize the clinical development plan and associated timelines. However, these strategies are generally being considered on an individual trial basis and not as part of a fully integrated overall development program. Such optimization at the trial level is somewhat near-sighted and does not ensure cost, time, or development efficiency of the overall program. This book seeks to address this imbalance by establishing a statistical framework for overall/global clinical development optimization and providing tactics and techniques to support such optimization, including clinical trial simulations.
- Provides a statistical framework for achieve global optimization in each phase of the drug development process.
- Describes specific techniques to support optimization including adaptive designs, precision medicine, survival-endpoints, dose finding and multiple testing.
- Gives practical approaches to handling missing data in clinical trials using SAS.
- Looks at key controversial issues from both a clinical and statistical perspective.
- Presents a generous number of case studies from multiple therapeutic areas that help motivate and illustrate the statistical methods introduced in the book.
- Puts great emphasis on software implementation of the statistical methods with multiple examples of software code (both SAS and R).
It is important for statisticians to possess a deep knowledge of the drug development process beyond statistical considerations. For these reasons, this book incorporates both statistical and "clinical/medical" perspectives.
Productspecificaties
Inhoud
- Taal
- en
- Bindwijze
- Paperback
- Oorspronkelijke releasedatum
- 30 juni 2021
- Aantal pagina's
- 376
- Illustraties
- Nee
Betrokkenen
- Hoofdauteur
- Mark Chang
- Tweede Auteur
- John Balser
- Co Auteur
- Jim Roach
- Hoofduitgeverij
- Chapman & Hall/Crc
Overige kenmerken
- Product breedte
- 156 mm
- Product lengte
- 234 mm
- Studieboek
- Nee
- Verpakking breedte
- 156 mm
- Verpakking hoogte
- 234 mm
- Verpakking lengte
- 234 mm
- Verpakkingsgewicht
- 535 g
EAN
- EAN
- 9781032093505
Je vindt dit artikel in
- Categorieën
- Beschikbaarheid
- Leverbaar
- Boek, ebook of luisterboek?
- Boek
- Taal
- Engels
- Studieboek of algemeen
- Studieboeken
- Prijs inclusief verzendkosten, verstuurd door bol
- Ophalen bij een bol afhaalpunt mogelijk
- 30 dagen bedenktijd en gratis retourneren
- Dag en nacht klantenservice
Rapporteer dit artikel
Je wilt melding doen van illegale inhoud over dit artikel:
- Ik wil melding doen als klant
- Ik wil melding doen als autoriteit of trusted flagger
- Ik wil melding doen als partner
- Ik wil melding doen als merkhouder
Geen klant, autoriteit, trusted flagger, merkhouder of partner? Gebruik dan onderstaande link om melding te doen.